Jugular vein thrombosis with severe local and systemic inflammation in a woman with ovarian hyperstimulation syndrome

• References

• 1 Rosene-Montella K, Keely E, Laifer SA, Lee RV. Evaluation and management of infertility in women: the internists’role. Ann Intern Med 2000; 132: 973-81.
• 2 Stewart JA, Hamilton PJ, Murdoch AP. Thromboembolic disease associated with ovarian stimulation and assisted conception techniques. Human Reprod 1997; 12: 2167-73.
• 3 Arya R, Shehata HA, Patel RK. et al. Internal jugular vein thrombosis after assisted conception therapy. Br J Hematol 2001; 115: 153-5.
• 4 Ellis MH, Nun IB, Rathaus V. et al. Internal jugular vein thrombosis in patients with ovarian hyperstimulation syndrome. Fertil Steril 1998; 69: 140-2.
• 5 Hignett M, Spence JF, Claman P. Internal jugular vein thrombosis: a late complication of ovarian hyperstimulation syndrome despite mini-dose heparin prophylaxis. Hum Reprod 1995; 10: 3121-3.
• 6 Barak V, Elchalal U, Edelstein M. et al. Interleukin-18 levels correlate with severe ovarian hyperstimulation syndrome. Fertil Steril 2004; 82: 415-20.
• 7 Elchalal U, Schenker JG. The pathophysiology of ovarian hyperstimulation syndrome – views and ideas. Hum Reprod 1997; 12: 1129-37.
• 8 Alanen A, Kormano M. Correlation of the echogenicity and structure of clotted blood. J Ultrasound Med 1985; 04: 421-5.
• 9 Goldhagen J, Alford BA, Prewitt LH. et al. Suppurative thrombophlebitis of the internal jugular vein: report of three cases and review of the pediatric literature. Pediatr Infect Dis J 1988; 07: 410-4.
• 10 Kodama H, Fukuda J, Karube H. et al. Characteristics of blood hemostatic markers in a patient with ovarian hyperstimulation syndrome who actually developed thromboembolism. Fertil Steril 1995; 64: 1207-9.
• 11 Fábregies F, Balasch J, Manau D. et al. Haematoctit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndrome. Human Reprod 1998; 13: 2406-10.
• 12 Levin I, Gamzu R, Pauzner D. Elevated levels of CRP in ovarian hyperstimulation syndrome: an unrecognized potential hazard?. BJOG 2005; 112: 952-5.
• 13 Horstkamp B, Lubke M, Kentenich H. et al. Internal jugular vein thrombosis caused by resistance to activated protein C as a complication of ovarian hyperstimulation after in-vitro fertilization. Hum Reprod 1996; 11: 280-2.
• 14 Dulitzky M, Cohen SB, Inbal A. et al. Increased prevalence of thrombophilia among women with severe ovarian hyperstimulation syndrome. Fertl Steril 2002; 77: 463-7.
• 15 Fabregues F, Tassies D, Reverter JC. et al. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening. Fertil Steril 2004; 81: 989-95.
• 16 Martinelli I, Sacchi E, Landi G. et al. High risk of cerebral-vein thrombosis in carriers ofa prothrombingene mutation and in users of oral contraceptives. NEJM 1998; 338: 1793-7.